Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Thromboprophylaxis in Patients Undergoing Orthopedic Surgeries; Focus on Cost-effective Analysis and Safety Comparison Between Rivaroxaban and Enoxaparin

NCT03299296 is registered in ClinicalTrials.gov with Ahmed AbdelMoneim Hassan Ali as lead sponsor.

NCT NCT03299296
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03299296 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Thromboprophylaxis in Patients Undergoing Orthopedic Surgeries; Focus on Cost-effective Analysis and Safety Comparison Between Rivaroxaban and Enoxaparin
Lead sponsor
Ahmed AbdelMoneim Hassan Ali
Phase
Phase 3
Overall status
Unknown status
Start date
January 1, 2017
Completion date
March 30, 2018
Enrollment
100 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

surgery--complications, thromboses, deep vein